Exec Chat: Kees Wesdorp Leads Philips' Advancement Of Precision Diagnosis During COVID-19
Kees Wesdorp, the leader of Philips' Precision Diagnosis business cluster told Medtech Insight how the division is delivering on digital solutions, beyond acute care, to drive a response to the COVID-19 pandemic
You may also be interested in...
The Dutch company received the US FDA's breakthrough device designation in 2018 for the surgical patch.
Johnson & Johnson previously agreed to acquire TachoSil but terminated the transaction due to regulatory hurdles.
Emmanuel Ligner, president and CEO of Cytiva, talks to In Vivo about how the company will dramatically increase its manufacturing capabilities over the next five years, at a price tag of $500m.